Okragly AJ - Search Results

1

Interleukin-33 Contributes Toward Loss of Tolerance by Promoting B-Cell-Activating Factor of the Tumor-Necrosis-Factor Family (BAFF)-Dependent Autoantibody Production.

Rose WA 2nd, Okragly AJ, Hu NN, Daniels MR, Martin AP, Koh YT, Kikly K, Benschop RJ. Rose WA 2nd, et al. Among authors: okragly aj. Front Immunol. 2018 Dec 6;9:2871. doi: 10.3389/fimmu.2018.02871. eCollection 2018. Front Immunol. 2018. PMID: 30574145 Free PMC article.

2

LIGHT-deficiency impairs CD8+ T cell expansion, but not effector function.

Liu J, Schmidt CS, Zhao F, Okragly AJ, Glasebrook A, Fox N, Galbreath E, Zhang Q, Song HY, Na S, Yang DD. Liu J, et al. Among authors: okragly aj. Int Immunol. 2003 Jul;15(7):861-70. doi: 10.1093/intimm/dxg082. Int Immunol. 2003. PMID: 12807825

3

Tumor-derived death receptor 6 modulates dendritic cell development.

DeRosa DC, Ryan PJ, Okragly A, Witcher DR, Benschop RJ. DeRosa DC, et al. Cancer Immunol Immunother. 2008 Jun;57(6):777-87. doi: 10.1007/s00262-007-0413-1. Epub 2007 Oct 26. Cancer Immunol Immunother. 2008. PMID: 17962943 Free PMC article.

4

IL-33 released by alum is responsible for early cytokine production and has adjuvant properties.

Rose WA 2nd, Okragly AJ, Patel CN, Benschop RJ. Rose WA 2nd, et al. Among authors: okragly aj. Sci Rep. 2015 Aug 14;5:13146. doi: 10.1038/srep13146. Sci Rep. 2015. PMID: 26272855 Free PMC article.

5

Elevated levels of Interleukin (IL)-33 induce bone pathology but absence of IL-33 does not negatively impact normal bone homeostasis.

Okragly AJ, Hamang MJ, Pena EA, Baker HE, Bullock HA, Lucchesi J, Martin AP, Ma YL, Benschop RJ. Okragly AJ, et al. Cytokine. 2016 Mar;79:66-73. doi: 10.1016/j.cyto.2015.12.011. Epub 2016 Jan 6. Cytokine. 2016. PMID: 26771472

6

Human mast cells release the migraine-inducing factor pituitary adenylate cyclase-activating polypeptide (PACAP).

Okragly AJ, Morin SM, DeRosa D, Martin AP, Johnson KW, Johnson MP, Benschop RJ. Okragly AJ, et al. Cephalalgia. 2018 Aug;38(9):1564-1574. doi: 10.1177/0333102417740563. Epub 2017 Nov 5. Cephalalgia. 2018. PMID: 29103295

7

Generation and Characterization of Torudokimab (LY3375880): A Monoclonal Antibody That Neutralizes Interleukin-33.

Okragly AJ, Corwin KB, Elia M, He D, Schroeder O, Zhang Q, Shiyanova T, Bright S, Dicker SB, Chlewicki L, Truhlar SME, Davies J, Patel CN, Benschop RJ. Okragly AJ, et al. J Inflamm Res. 2021 Aug 11;14:3823-3835. doi: 10.2147/JIR.S320287. eCollection 2021. J Inflamm Res. 2021. PMID: 34408465 Free PMC article.

8

Binding, Neutralization and Internalization of the Interleukin-13 Antibody, Lebrikizumab.

Okragly AJ, Ryuzoji A, Wulur I, Daniels M, Van Horn RD, Patel CN, Benschop RJ. Okragly AJ, et al. Dermatol Ther (Heidelb). 2023 Jul;13(7):1535-1547. doi: 10.1007/s13555-023-00947-7. Epub 2023 Jun 13. Dermatol Ther (Heidelb). 2023. PMID: 37310643 Free PMC article.

9

Bovine gamma/delta T-cell proliferation is associated with self-derived molecules constitutively expressed in vivo on mononuclear phagocytes.

Okragly AJ, Hanby-Flarida M, Mann D, Baldwin CL. Okragly AJ, et al. Immunology. 1996 Jan;87(1):71-9. Immunology. 1996. PMID: 8666438 Free PMC article.

10

Monocytes control gamma/delta T-cell responses by a secreted product.

Okragly AJ, Hanby-Flarida M, Baldwin CL. Okragly AJ, et al. Immunology. 1995 Dec;86(4):599-605. Immunology. 1995. PMID: 8567027 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

21 results

Search Page

Filters